Talkspace, Inc.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Revenues $38.2m
$76.2m +99.57%
$113.7m +49.19%
$119.6m +5.19%
$150.0m +25.49%
$187.6m +25.02%
$228.9m +22.00%
$245.7m +7.37%
Cost of revenue, excluding depreciation and amortization $18.0m
$26.4m +46.06%
$46.9m +77.96%
$59.2m +26.29%
$75.2m +27.00%
$101.3m +34.69%
$130.5m +28.83%
$143.7m +10.13%
Gross Profit $20.1m
$49.8m +147.50%
$66.8m +33.98%
$60.3m -9.64%
$74.8m +24.01%
$86.3m +15.31%
$98.3m +13.99%
$102.0m +3.69%
Research and development, net $12.0m $9.6m $15.9m $21.7m $17.6m $10.5m $9.5m $9.1m
Sales and marketing $27.5m $47.7m $100.6m $72.8m $52.5m $50.7m $53.8m
General and administrative $5.4m $1.8m $34.8m $36.3m $21.3m $22.6m $21.8m $30.1m
Total costs and operating expenses $49.6m $71.8m $160.7m $143.5m $97.6m $90.3m $225.7m
Income (loss) before income taxes ($29.1m) ($1.5m) ($62.7m) ($79.4m) ($19.0m) $1.2m $8.4m
Income tax expense $8k ($10k) $47k $254k $218k $94k $574k $510k
Net income (loss) ($29.1m)
($1.6m) +94.64%
($62.7m) -3926.84%
($79.7m) -26.98%
($19.2m) +75.92%
$1.1m +105.98%
$7.8m +578.83%
$194k -97.51%
Basic ($1.67) ($0.72) ($0.51) ($0.12) $0.01 $0.05 $0.00
Diluted ($1.67) ($0.72) ($0.51) ($0.12) $0.01 $0.04 $194,000.00
Clinical operations, net $4.7m $4.3m $9.4m $6.6m $6.2m $6.5m $7.2m
Depreciation and amortization $1.3m $859k $2.9m $4.6m
Income (loss) from operations ($29.4m)
($1.8m) +93.96%
($93.9m) -5187.55%
($83.2m) +11.46%
($23.2m) +72.09%
($4.5m) +80.62%
$3.2m +170.09%
($3.2m) -201.94%
Financial income, net ($350k) $364k ($31.2m) ($3.7m) ($4.2m) ($5.7m) ($5.2m)